These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35439022)

  • 1. Targeting AML at the intersection of epigenetics and signaling.
    Narayan N; Huntly BJP
    Sci Signal; 2022 Apr; 15(730):eabo0059. PubMed ID: 35439022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of epigenetic therapy in myelodysplastic syndromes and acute myeloid leukemia.
    Gonzalez-Lugo JD; Chakraborty S; Verma A; Shastri A
    Semin Hematol; 2021 Jan; 58(1):56-65. PubMed ID: 33509444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic determinants of AML pathogenesis.
    Cai SF; Levine RL
    Semin Hematol; 2019 Apr; 56(2):84-89. PubMed ID: 30926095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations Synergize to Alter Epigenetic and Genomic Landscape of AML.
    Cancer Discov; 2021 Dec; 11(12):OF8. PubMed ID: 34598942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in
    Shih AH; Meydan C; Shank K; Garrett-Bakelman FE; Ward PS; Intlekofer AM; Nazir A; Stein EM; Knapp K; Glass J; Travins J; Straley K; Gliser C; Mason CE; Yen K; Thompson CB; Melnick A; Levine RL
    Cancer Discov; 2017 May; 7(5):494-505. PubMed ID: 28193779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of IDH mutations in acute myeloid leukemia.
    Montalban-Bravo G; DiNardo CD
    Future Oncol; 2018 Apr; 14(10):979-993. PubMed ID: 29543066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of signal transducer and activator of transcription 3 in acute myeloid leukemia.
    Ghoshal Gupta S; Baumann H; Wetzler M
    Leuk Res; 2008 Jul; 32(7):1005-14. PubMed ID: 18192010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Clinical Update of Acute Myeloid Leukemia: Focus on Epigenetic Therapies.
    Lee E; Koh Y; Hong J; Eom HS; Yoon SS
    J Korean Med Sci; 2021 Apr; 36(13):e85. PubMed ID: 33821592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners.
    Sandoval JE; Huang YH; Muise A; Goodell MA; Reich NO
    J Biol Chem; 2019 Mar; 294(13):4898-4910. PubMed ID: 30705090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
    Newcombe AA; Gibson BES; Keeshan K
    Exp Hematol; 2018 Jul; 63():1-11. PubMed ID: 29608923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel oncogenic mutations of CBL in human acute myeloid leukemia that activate growth and survival pathways depend on increased metabolism.
    Fernandes MS; Reddy MM; Croteau NJ; Walz C; Weisbach H; Podar K; Band H; Carroll M; Reiter A; Larson RA; Salgia R; Griffin JD; Sattler M
    J Biol Chem; 2010 Oct; 285(42):32596-605. PubMed ID: 20622007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.
    Chatterjee SS; Biswas M; Boila LD; Banerjee D; Sengupta A
    Mol Cancer Res; 2018 May; 16(5):791-804. PubMed ID: 29483235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics in AML.
    Melnick AM
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFEB links MYC signaling to epigenetic control of myeloid differentiation and acute myeloid leukemia.
    Yun S; Vincelette ND; Yu X; Watson GW; Fernandez MR; Yang C; Hitosugi T; Cheng CH; Freischel AR; Zhang L; Li W; Hou H; Schaub FX; Vedder AR; Cen L; McGraw KL; Moon J; Murphy DJ; Ballabio A; Kaufmann SH; Berglund AE; Cleveland JL
    Blood Cancer Discov; 2021 Mar; 2(2):162-185. PubMed ID: 33860275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorafenib induces paradoxical phosphorylation of the extracellular signal-regulated kinase pathway in acute myeloid leukemia cells lacking FLT3-ITD mutation.
    Fouladi F; Jehn LB; Metzelder SK; Hub F; Henkenius K; Burchert A; Brendel C; Stiewe T; Neubauer A
    Leuk Lymphoma; 2015; 56(9):2690-8. PubMed ID: 25665465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Kat2a enhances transcriptional noise and depletes acute myeloid leukemia stem-like cells.
    Domingues AF; Kulkarni R; Giotopoulos G; Gupta S; Vinnenberg L; Arede L; Foerner E; Khalili M; Adao RR; Johns A; Tan S; Zeka K; Huntly BJ; Prabakaran S; Pina C
    Elife; 2020 Jan; 9():. PubMed ID: 31985402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia.
    Palma CA; Al Sheikha D; Lim TK; Bryant A; Vu TT; Jayaswal V; Ma DD
    Mol Cancer; 2014 Apr; 13():79. PubMed ID: 24708856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetics of paediatric acute myeloid leukaemia.
    Jones L; McCarthy P; Bond J
    Br J Haematol; 2020 Jan; 188(1):63-76. PubMed ID: 31804725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biomarkers in acute myeloid leukemia.
    Prada-Arismendy J; Arroyave JC; Röthlisberger S
    Blood Rev; 2017 Jan; 31(1):63-76. PubMed ID: 27639498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia.
    Tabe Y; Tafuri A; Sekihara K; Yang H; Konopleva M
    Expert Opin Ther Targets; 2017 Jul; 21(7):705-714. PubMed ID: 28537457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.